Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

LABP

Landos Biopharma (LABP)

Landos Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LABP
DateTimeSourceHeadlineSymbolCompany
03/25/20248:31AMPR Newswire (US)AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune DiseasesNASDAQ:LABPLandos Biopharma Inc
03/25/20248:30AMGlobeNewswire Inc.AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune DiseasesNASDAQ:LABPLandos Biopharma Inc
03/04/20244:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABPLandos Biopharma Inc
03/04/20244:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABPLandos Biopharma Inc
02/14/20244:01PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:LABPLandos Biopharma Inc
01/04/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABPLandos Biopharma Inc
11/21/20238:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABPLandos Biopharma Inc
11/09/20238:22AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LABPLandos Biopharma Inc
11/09/20238:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABPLandos Biopharma Inc
09/21/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABPLandos Biopharma Inc
09/14/20238:11AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABPLandos Biopharma Inc
08/09/20238:18AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LABPLandos Biopharma Inc
08/09/20238:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABPLandos Biopharma Inc
06/01/20234:20PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:LABPLandos Biopharma Inc
05/25/20234:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LABPLandos Biopharma Inc
05/24/20235:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LABPLandos Biopharma Inc
05/24/20235:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LABPLandos Biopharma Inc
05/24/20235:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LABPLandos Biopharma Inc
05/24/20235:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LABPLandos Biopharma Inc
05/24/20235:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LABPLandos Biopharma Inc
05/12/20238:48AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LABPLandos Biopharma Inc
05/12/20238:41AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LABPLandos Biopharma Inc
04/19/20238:06AMEdgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:LABPLandos Biopharma Inc
04/19/20238:01AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:LABPLandos Biopharma Inc
03/30/20235:28PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LABPLandos Biopharma Inc
03/23/20238:58AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:LABPLandos Biopharma Inc
03/23/20238:31AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:LABPLandos Biopharma Inc
03/23/20238:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LABPLandos Biopharma Inc
03/02/20234:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LABPLandos Biopharma Inc
03/02/20234:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LABPLandos Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:LABP